everolimus
Not Tagged
['everest', 'gucsm', 'rcc,(-irccs),(-srcc),(-urcc)']
everest study of 12 months adjuvant everolimus in rcc. several updates on study design, final analysis without all prespecified events.
almost half of patients in everolimus arm discontinued treatment #asco22 #gucsm 
??????????? ??? ????????. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.